MedTrace Logo

Retrospective Observational Study About Long-term Effect of Fampridine in Patients With Multiple Sclerosis

NCT02966808 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-02-10

No results posted yet for this study

Summary

Mobility problems in multiple sclerosis (MS) is a frequent symptom. It might appear in almost 93% of patients in the first 15 years of the disease, being a clear problem for their normal living. Nevertheless, therapeutic options for this symptom are few and optimal for only some patients.

Conditions

Interventions

BEHAVIORAL

cognitive and behavioural questionnaires

Sponsors & Collaborators

  • Hospital General Universitario Gregorio Marañon

    lead OTHER

Principal Investigators

  • Maria Luisa Martínez-Ginés, MD · Neurologist

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02966808 on ClinicalTrials.gov